2025-2031 Global Medical Collagen Industry Research & Trends Analysis Report- YH Research

日本语 | 中文

Home > Reports >Pharma & Healthcare > 2025-2031 Global Medical Collagen Industry Research & Trends Analysis Report

2025-2031 Global Medical Collagen Industry Research & Trends Analysis Report

Publication Date: 2025-11-28
Report Id: 2856382
Industry: Pharma & Healthcare
Report Page: 137
Chart: 133

PDF Download

Publication Date: 2025-11-28
Report Id: 2856382
Industry: Pharma & Healthcare
Report Page: 137
Chart: 133

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Medical Collagen Definition
1.2 Global Medical Collagen Market Size and Forecast
1.2.1 By Revenue, Global Medical Collagen Market Size, 2020-2031
1.2.2 By Sales Volume, Global Medical Collagen Market Size, 2020-2031
1.2.3 Global Medical Collagen Price Trend, 2020-2031
1.3 China Medical Collagen Market Size and Forecast
1.3.1 By Revenue, China Medical Collagen Market Size, 2020-2031
1.3.2 By Sales Volume, China Medical Collagen Market Size, 2020-2031
1.3.3 China Medical Collagen Price Trend, 2020-2031
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Medical Collagen Share in Global Market, 2020-2031
1.4.2 By Sales Volume, China Medical Collagen Share in Global Market, 2020-2031
1.4.3 Medical Collagen Market Size: China VS Global, 2020-2031
1.5 Medical Collagen Market Dynamics
1.5.1 Medical Collagen Market Drivers
1.5.2 Medical Collagen Market Restraints
1.5.3 Medical Collagen Industry Trends
1.5.4 Medical Collagen Industry Policy

2 Global Competitive Landscape by Company
2.1 Global Medical Collagen Revenue by Company, 2020-2025
2.2 Global Medical Collagen Sales Volume by Company, 2020-2025
2.3 Global Medical Collagen Price by Company, 2020-2025
2.4 Global Medical Collagen Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Medical Collagen Concentration Ratio
2.6 Global Medical Collagen Mergers & Acquisitions, Expansion Plans
2.7 Global Medical Collagen Manufacturers Product Type

3 China Competitive Landscape by Company
3.1 China Medical Collagen Revenue by Company, 2020-2025
3.2 China Medical Collagen Sales Volume by Company, 2020-2025
3.3 China Medical Collagen Medical Collagen Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.4 China Medical Collagen Market, Sales Percentage of Local Players VS Foreign Players (2020-2025)
3.5 Chinese Local Players, Medical Collagen Domestic VS Export
3.6 China Market, Medical Collagen Import & Export
3.6.1 China Market, Medical Collagen Import & Export, 2020-2031
3.6.2 China Medical Collagen Import & Export Trends
3.6.3 Main Sources of China Medical Collagen Import
3.6.4 Export Destination of China Medical Collagen

4 Medical Collagen Production by Region
4.1 Global Medical Collagen Capacity, Production and Capacity Utilization, 2020-2031
4.2 Global Geographic Distribution of Medical Collagen Manufacturers
4.3 Global Major Manufacturers, Medical Collagen Capacity Expansion and Future Plans
4.4 Global Medical Collagen Capacity by Region
4.5 Global Medical Collagen Production by Region
4.5.1 Global Medical Collagen Production & Forecast by Region, 2020 VS 2024 VS 2031
4.5.2 Global Medical Collagen Production by Region, 2020-2025
4.5.3 Global Medical Collagen Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Medical Collagen Industry Chain
5.2 Medical Collagen Upstream Analysis
5.2.1 Medical Collagen Core Raw Materials
5.2.2 Main Manufacturers of Medical Collagen Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Medical Collagen Production Mode
5.6 Medical Collagen Procurement Model
5.7 Medical Collagen Industry Sales Model and Sales Channels
5.7.1 Medical Collagen Sales Model
5.7.2 Medical Collagen Typical Distributors

6 Sights by Delivery Form
6.1 Medical Collagen Classification by Delivery Form
6.1.1 Solution
6.1.2 Fibrous Powder
6.1.3 Gel/Suspension
6.1.4 Sheet/Sponge Intermediate
6.2 by Delivery Form, Global Medical Collagen Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Delivery Form, Global Medical Collagen Revenue, 2020-2031
6.4 by Delivery Form, Global Medical Collagen Sales Volume, 2020-2031
6.5 by Delivery Form, Global Medical Collagen Price, 2020-2031

7 Sights by Source Type
7.1 Medical Collagen Classification by Source Type
7.1.1 Bovine Derived
7.1.2 Porcine Derived
7.1.3 Equine Derived
7.1.4 Marine Derived
7.1.5 Human/Allograft
7.1.6 Recombinant Human
7.2 by Source Type, Global Medical Collagen Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Source Type, Global Medical Collagen Revenue, 2020-2031
7.4 by Source Type, Global Medical Collagen Sales Volume, 2020-2031
7.5 by Source Type, Global Medical Collagen Price, 2020-2031

8 Sights by Collagen Type
8.1 Medical Collagen Classification by Collagen Type
8.1.1 Type I
8.1.2 Type II
8.1.3 Type III
8.2 by Collagen Type, Global Medical Collagen Market Size & CAGR, 2020 VS 2024 VS 2031
8.3 by Collagen Type, Global Medical Collagen Revenue, 2020-2031
8.4 by Collagen Type, Global Medical Collagen Sales Volume, 2020-2031
8.5 by Collagen Type, Global Medical Collagen Price, 2020-2031

9 Sights by Extraction Processing
9.1 Medical Collagen Classification by Extraction Processing
9.1.1 Atelocollagen (Pepsin)
9.1.2 Telocollagen (Native)
9.1.3 Insoluble Native Fibers
9.1.4 Recombinant Platform
9.2 by Extraction Processing, Global Medical Collagen Market Size & CAGR, 2020 VS 2024 VS 2031
9.3 by Extraction Processing, Global Medical Collagen Revenue, 2020-2031
9.4 by Extraction Processing, Global Medical Collagen Sales Volume, 2020-2031
9.5 by Extraction Processing, Global Medical Collagen Price, 2020-2031

10 Sights by Application
10.1 Medical Collagen Segment by Application
10.1.1 Biosurgery Hemostats and Sealants Base
10.1.2 Dental and Oral Barrier Membranes Base
10.1.3 Dura and Soft-Tissue Repair Base
10.1.4 Wound and Burn Dressings Base
10.1.5 Aesthetic Fillers and Skin Regeneration Base
10.1.6 Tissue Engineering and Bioprinting
10.2 by Application, Global Medical Collagen Market Size & CAGR, 2020 VS 2024 VS 2031
10.3 by Application, Global Medical Collagen Revenue, 2020-2031
10.4 by Application, Global Medical Collagen Sales Volume, 2020-2031
10.5 by Application, Global Medical Collagen Price, 2020-2031

11 Sales Sights by Region
11.1 By Region, Global Medical Collagen Market Size, 2020 VS 2024 VS 2031
11.2 By Region, Global Medical Collagen Revenue, 2020-2031
11.3 By Region, Global Medical Collagen Sales Volume, 2020-2031
11.4 North America
11.4.1 North America Medical Collagen Market Size & Forecasts, 2020-2031
11.4.2 By Country, North America Medical Collagen Market Size Market Share
11.5 Europe
11.5.1 Europe Medical Collagen Market Size & Forecasts, 2020-2031
11.5.2 By Country, Europe Medical Collagen Market Size Market Share
11.6 Asia Pacific
11.6.1 Asia Pacific Medical Collagen Market Size & Forecasts, 2020-2031
11.6.2 By Country/Region, Asia Pacific Medical Collagen Market Size Market Share
11.7 South America
11.7.1 South AmericaMedical Collagen Market Size & Forecasts, 2020-2031
11.7.2 By Country, South America Medical Collagen Market Size Market Share
11.8 Middle East & Africa

12 Sales Sights by Country Level
12.1 By Country, Global Medical Collagen Market Size & CAGR，2020 VS 2024 VS 2031
12.2 By Country, Global Medical Collagen Revenue, 2020-2031
12.3 By Country, Global Medical Collagen Sales Volume, 2020-2031
12.4 United States
12.4.1 United States Medical Collagen Market Size, 2020-2031
12.4.2 By Company, United States Medical Collagen Sales Volume Market Share, 2024
12.4.3 by Delivery Form, United States Medical Collagen Market Size, Share, 2024 VS 2031
12.4.4 by Application, United States Medical Collagen Market Size, Share, 2024 VS 2031
12.5 Europe
12.5.1 Europe Medical Collagen Market Size, 2020-2031
12.5.2 By Company, Europe Medical Collagen Sales Volume Market Share, 2024
12.5.3 by Delivery Form, Europe Medical Collagen Market Size, Share, 2024 VS 2031
12.5.4 by Application, Europe Medical Collagen Market Size, Share, 2024 VS 2031
12.6 China
12.6.1 China Medical Collagen Market Size, 2020-2031
12.6.2 By Company, China Medical Collagen Sales Volume Market Share, 2024
12.6.3 by Delivery Form, China Medical Collagen Market Size, Share, 2024 VS 2031
12.6.4 by Application, China Medical Collagen Market Size, Share, 2024 VS 2031
12.7 Japan
12.7.1 Japan Medical Collagen Market Size, 2020-2031
12.7.2 By Company, Japan Medical Collagen Market Share, 2024
12.7.3 by Delivery Form, Japan Medical Collagen Market Size, Share, 2024 VS 2031
12.7.4 by Application, Japan Medical Collagen Market Size, Share, 2024 VS 2031
12.8 South Korea
12.8.1 South Korea Medical Collagen Market Size, 2020-2031
12.8.2 By Company, South Korea Medical Collagen Market Share, 2024
12.8.3 by Delivery Form, South Korea Medical Collagen Market Size, Share, 2024 VS 2031
12.8.4 by Application, South Korea Medical Collagen Market Size, Share, 2024 VS 2031
12.9 Southeast Asia
12.9.1 Southeast Asia Medical Collagen Market Size, 2020-2031
12.9.2 By Company, Southeast Asia Medical Collagen Market Share, 2024
12.9.3 by Delivery Form, Southeast Asia Medical Collagen Market Size, Share, 2024 VS 2031
12.9.4 by Application, Southeast Asia Medical Collagen Market Size, Share, 2024 VS 2031
12.10 India
12.10.1 India Medical Collagen Market Size, 2020-2031
12.10.2 By Company, India Medical Collagen Market Share, 2024
12.10.3 by Delivery Form, India Medical Collagen Market Size, Share, 2024 VS 2031
12.10.4 by Application, India Medical Collagen Market Size, Share, 2024 VS 2031
12.11 Middle East & Africa
12.11.1 Middle East & Africa Medical Collagen Market Size, 2020-2031
12.11.2 By Company, Middle East & Africa Medical Collagen Market Share, 2024
12.11.3 by Delivery Form, Middle East & Africa Medical Collagen Market Size, Share, 2024 VS 2031
12.11.4 by Application, Middle East & Africa Medical Collagen Market Size, Share, 2024 VS 2031

13 Manufacturers Profile
13.1 DSM Biomedical
13.1.1 DSM Biomedical Company Information, Head Office, Market Area, and Industry Position
13.1.2 DSM Biomedical Medical Collagen Models, Specifications, and Application
13.1.3 DSM Biomedical Medical Collagen Sales Volume, Revenue, Price and Gross Margin, 2020-2025
13.1.4 DSM Biomedical Company Profile and Main Business
13.1.5 DSM Biomedical Recent Developments
13.2 SUNMAX Biotech
13.2.1 SUNMAX Biotech Company Information, Head Office, Market Area, and Industry Position
13.2.2 SUNMAX Biotech Medical Collagen Models, Specifications, and Application
13.2.3 SUNMAX Biotech Medical Collagen Sales Volume, Revenue, Price and Gross Margin, 2020-2025
13.2.4 SUNMAX Biotech Company Profile and Main Business
13.2.5 SUNMAX Biotech Recent Developments
13.3 SYMATESE LAB
13.3.1 SYMATESE LAB Company Information, Head Office, Market Area, and Industry Position
13.3.2 SYMATESE LAB Medical Collagen Models, Specifications, and Application
13.3.3 SYMATESE LAB Medical Collagen Sales Volume, Revenue, Price and Gross Margin, 2020-2025
13.3.4 SYMATESE LAB Company Profile and Main Business
13.3.5 SYMATESE LAB Recent Developments
13.4 Nippi
13.4.1 Nippi Company Information, Head Office, Market Area, and Industry Position
13.4.2 Nippi Medical Collagen Models, Specifications, and Application
13.4.3 Nippi Medical Collagen Sales Volume, Revenue, Price and Gross Margin, 2020-2025
13.4.4 Nippi Company Profile and Main Business
13.4.5 Nippi Recent Developments
13.5 KOKEN
13.5.1 KOKEN Company Information, Head Office, Market Area, and Industry Position
13.5.2 KOKEN Medical Collagen Models, Specifications, and Application
13.5.3 KOKEN Medical Collagen Sales Volume, Revenue, Price and Gross Margin, 2020-2025
13.5.4 KOKEN Company Profile and Main Business
13.5.5 KOKEN Recent Developments
13.6 Viscofan BioEngineering
13.6.1 Viscofan BioEngineering Company Information, Head Office, Market Area, and Industry Position
13.6.2 Viscofan BioEngineering Medical Collagen Models, Specifications, and Application
13.6.3 Viscofan BioEngineering Medical Collagen Sales Volume, Revenue, Price and Gross Margin, 2020-2025
13.6.4 Viscofan BioEngineering Company Profile and Main Business
13.6.5 Viscofan BioEngineering Recent Developments
13.7 Collagen Solutions
13.7.1 Collagen Solutions Company Information, Head Office, Market Area, and Industry Position
13.7.2 Collagen Solutions Medical Collagen Models, Specifications, and Application
13.7.3 Collagen Solutions Medical Collagen Sales Volume, Revenue, Price and Gross Margin, 2020-2025
13.7.4 Collagen Solutions Company Profile and Main Business
13.7.5 Collagen Solutions Recent Developments
13.8 Acro Biomedical
13.8.1 Acro Biomedical Company Information, Head Office, Market Area, and Industry Position
13.8.2 Acro Biomedical Medical Collagen Models, Specifications, and Application
13.8.3 Acro Biomedical Medical Collagen Sales Volume, Revenue, Price and Gross Margin, 2020-2025
13.8.4 Acro Biomedical Company Profile and Main Business
13.8.5 Acro Biomedical Recent Developments
13.9 Advanced BioMatrix (BICO)
13.9.1 Advanced BioMatrix (BICO) Company Information, Head Office, Market Area, and Industry Position
13.9.2 Advanced BioMatrix (BICO) Medical Collagen Models, Specifications, and Application
13.9.3 Advanced BioMatrix (BICO) Medical Collagen Sales Volume, Revenue, Price and Gross Margin, 2020-2025
13.9.4 Advanced BioMatrix (BICO) Company Profile and Main Business
13.9.5 Advanced BioMatrix (BICO) Recent Developments
13.10 Shengchi Biotechnology
13.10.1 Shengchi Biotechnology Company Information, Head Office, Market Area, and Industry Position
13.10.2 Shengchi Biotechnology Medical Collagen Models, Specifications, and Application
13.10.3 Shengchi Biotechnology Medical Collagen Sales Volume, Revenue, Price and Gross Margin, 2020-2025
13.10.4 Shengchi Biotechnology Company Profile and Main Business
13.10.5 Shengchi Biotechnology Recent Developments
13.11 Chuang'er Biotechnology
13.11.1 Chuang'er Biotechnology Company Information, Head Office, Market Area, and Industry Position
13.11.2 Chuang'er Biotechnology Medical Collagen Models, Specifications, and Application
13.11.3 Chuang'er Biotechnology Medical Collagen Sales Volume, Revenue, Price and Gross Margin, 2020-2025
13.11.4 Chuang'er Biotechnology Company Profile and Main Business
13.11.5 Chuang'er Biotechnology Recent Developments
13.12 Bedi Biotechnology
13.12.1 Bedi Biotechnology Company Information, Head Office, Market Area, and Industry Position
13.12.2 Bedi Biotechnology Medical Collagen Models, Specifications, and Application
13.12.3 Bedi Biotechnology Medical Collagen Sales Volume, Revenue, Price and Gross Margin, 2020-2025
13.12.4 Bedi Biotechnology Company Profile and Main Business
13.12.5 Bedi Biotechnology Recent Developments

14 Conclusion

15 Appendix
15.1 Research Methodology
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Market Estimation Model
15.4 Disclaimer

According to YH Research, the global market for Medical Collagen should grow from US$ 456 million in 2024 to US$ 698 million by 2031, with a CAGR of 6.5% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Medical Collagen

According to YH Research, the global market for Medical Collagen should grow from US$ 456 million in 2024 to US$ 698 million by 2031, with a CAGR of 6.5% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Medical Collagen are sterile, device-grade or device-intended collagens supplied as starting materials to medical-device makers and OEM/CDMOs. Covered forms include acid-soluble solutions, gels and suspensions of native or engineered fibers, fibrous powders, and sheet or sponge intermediates; the scope explicitly excludes finished hemostats, barrier membranes, dressings, dura or soft-tissue repair patches, and branded implants. Upstream, validated platforms extract and purify Type I collagen (and select Type II/III, blends, or recombinant human Type I) under ISO 13485 quality systems with low endotoxin, traceability, and sterilization controls. This upstream layer is codified by established standards that treat Type I collagen as a starting material for surgical implants and tissue-engineered products, and by device regulations that reference material characterization, sourcing, and biocompatibility. Procurement is typically anchored in framework agreements and qualification programs with device manufacturers, with private-label and OEM channels governed by the same quality documentation, change control, and batch consistency requirements. Typical gross margins sit in the mid-60s range, supported by regulatory barriers, multi-year validation, and customer lock-in around certified starting materials and handling protocols.

In the current market, global production is around 350 ton, with an average selling price of about 1225 USD per kg on an EXW basis. On the supply side, the market is organized around ISO-certified collagen platforms with clear starting-material positioning. A leading cluster offers ultrapure bovine Type I fibers and suspensions in research and medical grades, explicitly marketed as universal raw biomaterials for wound care, soft-tissue repair, tissue engineering, and device technologies. European suppliers with end-to-end extraction and purification disclose device-intended solutions, dry and fibrous forms, and intermediate sheets or sponges, supported by ISO 13485 and QSR-aligned quality systems. Long-established Japanese players provide multi-source portfolios—including bovine, porcine, and marine options—across solutions, powders, and sheet formats, as well as atelocollagen scaffolds obtained by pepsin treatment to reduce telopeptides. Recombinant routes have matured into plant-derived rhCollagen for bioinks and premium aesthetic or implant indications, capturing high value at low volumes due to purity, consistency, and human-sequence advantages. Global multinationals in biomaterials advertise medical-grade collagen manufactured in cGMP and ISO Class 8 environments with ISO 13485 certification, supplying both biomaterial components and finished matrices. Across suppliers, common commercial threads include starter-material catalogs, documented specifications, technical dossiers, and engineering support for customers’ downstream forming steps such as crosslinking, lyophilization, casting, coating, and compounding.

Structurally, the market shows moderate concentration with a top tier spanning Europe, North America, and Japan, and a long tail of regional OEMs and specialty processors. Demand is strongest in North America and Europe where reimbursement, operating-room hemostasis protocols, and dental and cranio-maxillofacial standards are entrenched; Asia Pacific—including China, Japan, and South Korea—is accelerating as implant dentistry, wound and burn care, and soft-tissue reconstruction scale. By product axis, bovine Type I dominates value given its broad compatibility with hemostats, barrier membranes, dura and soft-tissue repair, and dressings; porcine and equine serve regional preferences or specific handling targets; marine collagen addresses niche or ethical constraints; recombinant human collagen anchors bioprinting and select premium dermal and implant applications. Through 2025–2031, growth is shaped by operating-room efficiency and hemostasis protocols, guided bone regeneration in implant dentistry, and expanding soft-tissue reconstruction, while bottlenecks include qualified tissue sourcing and traceability, batch-to-batch consistency, sterilization capacity, EU MDR documentation load, and long verification and validation cycles. Strategic moves—such as explicit “starter-material” positioning, end-to-end extraction control, recombinant platform scaling, and OEM partnership models—reinforce that durable advantage stems less from commodity pricing and more from standardized characterization, ISO 13485 systems, and proven device pathways that shorten customers’ time from raw collagen to regulated implantable products.

This report aims to provide a comprehensive study of the global market for Medical Collagen. 
Report Highlights:
(1) Global Medical Collagen market size (sales volume & revenue), history data from 2020-2025, and forecast data from 2026 to 2031.

(2) Global Medical Collagen market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(3) China Medical Collagen market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(4) Global Medical Collagen segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Medical Collagen segment by Delivery Form, and by Application, and regional segment by Delivery Form, and by Application.

(6) Global major production regions of Medical Collagen, capacity, production and trends.

(7) Medical Collagen industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Delivery Form, covers
    Solution
    Fibrous Powder
    Gel/Suspension
    Sheet/Sponge Intermediate

Market segment by Source Type, covers
    Bovine Derived
    Porcine Derived
    Equine Derived
    Marine Derived
    Human/Allograft
    Recombinant Human

Market segment by Collagen Type, covers
    Type I
    Type II
    Type III

Market segment by Extraction Processing, covers
    Atelocollagen (Pepsin)
    Telocollagen (Native)
    Insoluble Native Fibers
    Recombinant Platform

Market segment by Application, can be divided into
    Biosurgery Hemostats and Sealants Base
    Dental and Oral Barrier Membranes Base
    Dura and Soft-Tissue Repair Base
    Wound and Burn Dressings Base
    Aesthetic Fillers and Skin Regeneration Base
    Tissue Engineering and Bioprinting

Market segment by players, this report covers
    DSM Biomedical
    SUNMAX Biotech
    SYMATESE LAB
    Nippi
    KOKEN
    Viscofan BioEngineering
    Collagen Solutions
    Acro Biomedical
    Advanced BioMatrix (BICO)
    Shengchi Biotechnology
    Chuang'er Biotechnology
    Bedi Biotechnology